Skip CCR Main Navigation National Cancer Institute National Cancer Institute U.S. National Institutes of Health
CCR - For Our Staff| Home |

Our Science – Pinto Website

Peter A. Pinto, M.D.

Selected Publications

1)  Logan JK, Walton-Diaz A, Rais-Bahrami S, Merino MJ, Turkbey B, Choyke PL, Pinto PA.
Changes observed in multiparametric prostate magnetic resonance imaging characteristics correlate with histopathological development of chronic granulomatous prostatitis after intravesical Bacillus Calmette-Guerin therapy.
J Comput Assist Tomogr. 38: 274-6, 2014.
2)  Turkbey B, Merino MJ, Gallardo EC, Shah V, Aras O, Bernardo M, Mena E, Daar D, Rastinehad AR, Linehan WM, Wood BJ, Pinto PA, Choyke PL.
Comparison of endorectal coil and nonendorectal coil T2W and diffusion-weighted MRI at 3 Tesla for localizing prostate cancer: correlation with whole-mount histopathology.
J Magn Reson Imaging. 39: 1443-8, 2014.
3)  Hong CW, Rais-Bahrami S, Walton-Diaz A, Shakir N, Su D, George AK, Merino MJ, Turkbey B, Choyke PL, Wood BJ, Pinto PA.
Comparison of MR-US fusion-guided prostate biopsies obtained from axial and sagittal approaches.
BJU Int. [Epub ahead of print], 2014.
4)  Rais-Bahrami S, Siddiqui MM, Vourganti S, Turkbey B, Rastinehad AR, Stamatakis L, Truong H, Walton-Diaz A, Hoang AN, Nix JW, Merino MJ, Wood BJ, Simon RM, Choyke PL, Pinto PA.
Diagnostic Value of Biparametric MRI as an Adjunct to PSA-based Detection of Prostate Cancer in Men without Prior Biopsies.
BJU Int. [Epub ahead of print], 2014.
5)  Farsaci B, Jochems C, Grenga I, Donahue RN, Tucker JA, Pinto PA, Merino MJ, Heery CR, Madan RA, Gulley JL, Schlom J.
Identification by digital immunohistochemistry of intratumoral changes of immune infiltrates after vaccine in the absence of modifications of PBMC immune cell subsets.
Int. J. Cancer. 135: 862-70, 2014.
6)  Shakir NA, George AK, Siddiqui MM, Rothwax JT, Rais-Bahrami S, Stamatakis L, Su D, Okoro C, Raskolnikov D, Walton-Diaz A, Simon R, Turkbey B, Choyke PL, Merino MJ, Wood BJ, Pinto PA.
Identification of threshold prostate-specific antigen levels to optimize the detection of clinically-significant prostate cancer by MRI/US fusion guided biopsy.
J. Urol. [Epub ahead of print], 2014.
7)  Hong CW, Walton-Diaz A, Rais-Bahrami S, Hoang AN, Türkbey B, Stamatakis L, Xu S, Amalou H, Siddiqui MM, Nix JW, Vourganti S, Merino MJ, Choyke PL, Wood BJ, Pinto PA.
Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session.
Diagn Interv Radiol. 20: 234-8, 2014.
8)  Muller BG, van den Bos W, Pinto PA, de la Rosette JJ.
Imaging modalities in focal therapy: patient selection, treatment guidance, and follow-up.
Curr Opin Urol. 24: 218-24, 2014.
9)  Turkbey B, Mena E, Shih J, Pinto PA, Merino MJ, Lindenberg ML, Bernardo M, McKinney YL, Adler S, Owenius R, Choyke PL, Kurdziel KA.
Localized prostate cancer detection with 18F FACBC PET/CT: comparison with MR imaging and histopathologic analysis.
Radiology. 270: 849-56, 2014.
10)  Johnson LM, Rothwax JT, Turkbey B, Rais-Bahrami S, Wood BJ, Figg WD, Choyke PL, Merino MJ, Pinto PA.
Multiparametric magnetic resonance imaging of the prostate AIDS to detect lesion progression.
J Comput Assist Tomogr. 38: 565-7, 2014.
11)  Volkin D, Turkbey B, Hoang AN, Rais-Bahrami S, Yerram N, Walton-Diaz A, Nix JW, Wood BJ, Choyke PL, Pinto PA.
Multiparametric MRI and Subsequent MR/Ultrasound Fusion-Guided Biopsy Increase the Detection of Anteriorly Located Prostate Cancers.
BJU Int. [Epub ahead of print], 2014.
12)  Rothwax JT, George AK, Wood BJ, Pinto PA.
Multiparametric MRI in Biopsy Guidance for Prostate Cancer: Fusion-Guided.
Biomed Res Int. 2014: 439171, 2014.
13)  Rais-Bahrami S, Türkbey B, Rastinehad AR, Walton-Diaz A, Hoang AN, Siddiqui MM, Stamatakis L, Truong H, Nix JW, Vourganti S, Grant KB, Merino MJ, Choyke PL, Pinto PA.
Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up.
Diagn Interv Radiol. 20: 293-8, 2014.
14)  Gupta GN, Benson JS, Ross MJ, Sundaram VS, Lin KY, Pinto PA, Linehan WM, Bratslavsky G.
Perioperative, functional, and oncologic outcomes of partial adrenalectomy for multiple ipsilateral pheochromocytomas.
J. Endourol. 28: 112-6, 2014.
15)  Hong CW, Amalou H, Xu S, Turkbey B, Yan P, Kruecker J, Pinto PA, Choyke PL, Wood BJ.
Prostate biopsy for the interventional radiologist.
J Vasc Interv Radiol. 25: 675-84, 2014.
16)  Rais-Bahrami S, Turkbey B, Grant KB, Pinto PA, Choyke PL.
Role of multiparametric magnetic resonance imaging in the diagnosis of prostate cancer.
Curr Urol Rep. 15: 387, 2014.
17)  Muller BG, Fütterer JJ, Gupta RT, Katz A, Kirkham A, Kurhanewicz J, Moul JW, Pinto PA, Rastinehad AR, Robertson C, de la Rosette J, Sanchez-Salas R, Jones JS, Ukimura O, Verma S, Wijkstra H, Marberger M.
The role of magnetic resonance imaging (MRI) in focal therapy for prostate cancer: recommendations from a consensus panel.
BJU Int. 113: 218-27, 2014.
18)  Xu H, Lasso A, Guion P, Krieger A, Kaushal A, Singh AK, Pinto PA, Coleman J, Grubb RL, Lattouf J, Menard C, Whitcomb LL, Fichtinger G.
Accuracy analysis in MRI-guided robotic prostate biopsy.
Int J Comput Assist Radiol Surg. 8: 937-44, 2013.
19)  Stamatakis L, Siddiqui MM, Nix JW, Logan J, Rais-Bahrami S, Walton-Diaz A, Hoang AN, Vourganti S, Truong H, Shuch B, Parnes HL, Turkbey B, Choyke PL, Wood BJ, Simon RM, Pinto PA.
Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer.
Cancer. 119: 3359-66, 2013.
20)  Ballester L, Aung P, Lai J, DiGiovanna J, Abdullaev Z, Pack S, Linehan W, Stern J, Pinto P, Lee C.
An unusual presentation of glomeruloid hemangioma in a patient with VHL syndrome: A case report and review of literature.
Open J Clin Diagn. 3(June): 1-4, 2013.
21)  Walton Diaz A, Hoang AN, Turkbey B, Hong CW, Truong H, Sterling T, Rais-Bahrami S, Siddiqui MM, Stamatakis L, Vourganti S, Nix J, Logan J, Harris C, Weintraub M, Chua C, Merino MJ, Choyke P, Wood BJ, Pinto PA.
Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates?.
J. Urol. 190: 2020-5, 2013.
22)  Metwalli AR, Pinto PA.
Commentary on: "Focal cryosurgical ablation of the prostate: a single institute"s perspective".
BMC Urol. 13: 39, 2013.
23)  Walter BA, Valera VA, Pinto PA, Merino MJ.
Comprehensive microRNA Profiling of Prostate Cancer.
J Cancer. 4: 350-7, 2013.
24)  Logan JK, Rais-Bahrami S, Turkbey B, Gomella A, Amalou H, Choyke PL, Wood BJ, Pinto PA.
Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies.
BJU Int. [Epub ahead of print], 2013.
25)  Wood BJ, Choyke P, Turkbey B, Pinto P.
Editorial comment.
J. Urol. 189: 92, 2013.
26)  Boris RS, Gupta GN, Benson JS, Linehan WM, Pinto PA, Bratslavsky G.
Feasibility and outcomes of laparoscopic renal intervention after prior open ipsilateral retroperitoneal surgery.
J. Endourol. 27: 196-201, 2013.
27)  Turkbey B, Fotin SV, Huang RJ, Yin Y, Daar D, Aras O, Bernardo M, Garvey BE, Weaver J, Haldankar H, Muradyan N, Merino MJ, Pinto PA, Periaswamy S, Choyke PL.
Fully automated prostate segmentation on MRI: comparison with manual segmentation methods and specimen volumes.
AJR Am J Roentgenol. 201: W720-9, 2013.
28)  Liu NW, Sanford T, Srinivasan R, Liu JL, Khurana K, Aprelikova O, Valero V, Bechert C, Worrell R, Pinto PA, Yang Y, Merino M, Linehan WM, Bratslavsky G.
Impact of ischemia and procurement conditions on gene expression in renal cell carcinoma.
Clin. Cancer Res. 19: 42-9, 2013.
29)  Pang Y, Turkbey B, Bernardo M, Kruecker J, Kadoury S, Merino MJ, Wood BJ, Pinto PA, Choyke PL.
Intravoxel incoherent motion MR imaging for prostate cancer: an evaluation of perfusion fraction and diffusion coefficient derived from different b-value combinations.
Magn Reson Med. 69: 553-62, 2013.
30)  Partanen A, Yerram NK, Trivedi H, Dreher MR, Oila J, Hoang AN, Volkin D, Nix J, Turkbey B, Bernardo M, Haines DC, Benjamin CJ, Linehan WM, Choyke P, Wood BJ, Ehnholm GJ, Venkatesan AM, Pinto PA.
Magnetic resonance imaging (MRI)-guided transurethral ultrasound therapy of the prostate: a preclinical study with radiological and pathological correlation using customised MRI-based moulds.
BJU Int. 112: 508-16, 2013.
31)  Siddiqui MM, Rais-Bahrami S, Truong H, Stamatakis L, Vourganti S, Nix J, Hoang AN, Walton-Diaz A, Shuch B, Weintraub M, Kruecker J, Amalou H, Turkbey B, Merino MJ, Choyke PL, Wood BJ, Pinto PA.
Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.
Eur. Urol. 64: 713-9, 2013.
32)  Truong H, Logan J, Turkbey B, Siddiqui MM, Rais-Bahrami S, Hoang AN, Pusateri C, Shuch B, Walton-Diaz A, Vourganti S, Nix J, Stamatakis L, Harris C, Chua C, Choyke PL, Wood BJ, Pinto PA.
MRI characterization of the dynamic effects of 5a-reductase inhibitors on prostate zonal volumes.
Can J Urol. 20: 7002-7, 2013.
33)  Gulley JL, Heery CR, Madan RA, Walter BA, Merino MJ, Dahut WL, Tsang KY, Schlom J, Pinto PA.
Phase I study of intraprostatic vaccine administration in men with locally recurrent or progressive prostate cancer.
Cancer Immunol. Immunother. 62: 1521-31, 2013.
34)  Turkbey B, Mani H, Aras O, Ho J, Hoang A, Rastinehad AR, Agarwal H, Shah V, Bernardo M, Pang Y, Daar D, McKinney YL, Linehan WM, Kaushal A, Merino MJ, Wood BJ, Pinto PA, Choyke PL.
Prostate Cancer: Can Multiparametric MR Imaging Help Identify Patients Who Are Candidates for Active Surveillance?.
Radiology. [Epub ahead of print], 2013.
35)  Gupta GN, Boris R, Chung P, Linehan WM, Pinto PA, Bratslavsky G.
Robot-assisted laparoscopic partial nephrectomy for tumors greater than 4 cm and high nephrometry score: feasibility, renal functional, and oncological outcomes with minimum 1 year follow-up.
Urol. Oncol. 31: 51-6, 2013.
36)  Muller BG, van den Bos W, Brausi M, Cornud F, Gontero P, Kirkham A, Pinto PA, Polascik TJ, Rastinehad AR, de Reijke TM, de la Rosette JJ, Ukimura O, Villers A, Walz J, Wijkstra H, Marberger M.
Role of multiparametric magnetic resonance imaging (MRI) in focal therapy for prostate cancer: a Delphi consensus project.
BJU Int. [Epub ahead of print], 2013.
37)  Rais-Bahrami S, Siddiqui MM, Turkbey B, Stamatakis L, Logan J, Hoang AN, Walton-Diaz A, Vourganti S, Truong H, Kruecker J, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer.
J. Urol. 190: 1721-7, 2013.
38)  Mena E, Turkbey B, Mani H, Adler S, Valera VA, Bernardo M, Shah V, Pohida T, McKinney Y, Kwarteng G, Daar D, Lindenberg ML, Eclarinal P, Wade R, Linehan WM, Merino MJ, Pinto PA, Choyke PL, Kurdziel KA.
11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.
J. Nucl. Med. 53: 538-45, 2012.
39)  Singer EA, Kaushal A, Turkbey B, Couvillon A, Pinto PA, Parnes HL.
Active surveillance for prostate cancer: past, present and future.
Curr Opin Oncol. 24: 243-50, 2012.
40)  Turkbey B, Huang R, Vourganti S, Trivedi H, Bernardo M, Yan P, Benjamin C, Pinto PA, Choyke PL.
Age-related changes in prostate zonal volumes as measured by high-resolution magnetic resonance imaging (MRI): a cross-sectional study in over 500 patients.
BJU Int. 110: 1642-7, 2012.
41)  Boyce AM, Chong WH, Shawker TH, Pinto PA, Linehan WM, Bhattacharryya N, Merino MJ, Singer FR, Collins MT.
Characterization and management of testicular pathology in McCune-Albright syndrome.
J. Clin. Endocrinol. Metab. 97: E1782-90, 2012.
42)  Turkbey B, Mani H, Aras O, Rastinehad AR, Shah V, Bernardo M, Pohida T, Daar D, Benjamin C, McKinney YL, Linehan WM, Wood BJ, Merino MJ, Choyke PL, Pinto PA.
Correlation of magnetic resonance imaging tumor volume with histopathology.
J. Urol. 188: 1157-63, 2012.
43)  Shah V, Turkbey B, Mani H, Pang Y, Pohida T, Merino MJ, Pinto PA, Choyke PL, Bernardo M.
Decision support system for localizing prostate cancer based on multiparametric magnetic resonance imaging.
Med Phys. 39: 4093-103, 2012.
44)  Agochukwu NQ, Metwalli AR, Kutikov A, Pinto PA, Linehan WM, Bratslavsky G.
Economic burden of repeat renal surgery on solitary kidney--do the ends justify the means? A cost analysis.
J. Urol. 188: 1695-700, 2012.
45)  Hoang AN, Volkin D, Yerram NK, Vourganti S, Nix J, Linehan WM, Wood B, Pinto PA.
Image guidance in the focal treatment of prostate cancer.
Curr Opin Urol. 22: 328-35, 2012.
46)  Yerram NK, Volkin D, Turkbey B, Nix J, Hoang AN, Vourganti S, Gupta GN, Linehan WM, Choyke PL, Wood BJ, Pinto PA.
Low suspicion lesions on multiparametric magnetic resonance imaging predict for the absence of high-risk prostate cancer.
BJU Int. 110: E783-8, 2012.
47)  Turkbey B, Bernardo M, Merino M, Wood B, Pinto P, Choyke P.
MRI of localized prostate cancer: coming of age in the PSA era.
Diagn Interv Radiol. 18: 34-45, 2012.
48)  Vourganti S, Rastinehad A, Yerram NK, Nix J, Volkin D, Hoang A, Turkbey B, Gupta GN, Kruecker J, Linehan WM, Choyke PL, Wood BJ, Pinto PA.
Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies.
J. Urol. 188: 2152-7, 2012.
49)  Singer EA, Vourganti S, Lin KY, Gupta GN, Pinto PA, Rastinehad AR, Linehan WM, Bratslavsky G.
Outcomes of patients with surgically treated bilateral renal masses and a minimum of 10 years of followup.
J. Urol. 188: 2084-8, 2012.
50)  Volkin D, Yerram N, Ahmed F, Lankford D, Baccala A, Gupta GN, Hoang A, Nix J, Metwalli AR, Lang DM, Bratslavsky G, Linehan WM, Pinto PA.
Partial adrenalectomy minimizes the need for long-term hormone replacement in pediatric patients with pheochromocytoma and von Hippel-Lindau syndrome.
J. Pediatr. Surg. 47: 2077-82, 2012.
51)  Agochukwu NQ, Rastinehad AR, Richter LA, Barak S, Zerbe CS, Holland SM, Pinto PA.
Prostatic abscess in a pediatric patient with chronic granulomatous disease: report of a unique case and review of the literature.
J. Pediatr. Surg. 47: 400-3, 2012.
52)  Ricketts CJ, Shuch B, Vocke CD, Metwalli AR, Bratslavsky G, Middelton L, Yang Y, Wei MH, Pautler SE, Peterson J, Stolle CA, Zbar B, Merino MJ, Schmidt LS, Pinto PA, Srinivasan R, Pacak K, Linehan WM.
Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer.
J. Urol. 188: 2063-71, 2012.
53)  Trivedi H, Turkbey B, Rastinehad AR, Benjamin CJ, Bernardo M, Pohida T, Shah V, Merino MJ, Wood BJ, Linehan WM, Venkatesan AM, Choyke PL, Pinto PA.
Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer.
Urology. 79: 233-9, 2012.
54)  Nix JW, Turkbey B, Hoang A, Volkin D, Yerram N, Chua C, Linehan WM, Wood B, Choyke P, Pinto PA.
Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla.
BJU Int. 110: E694-700, 2012.
55)  Liu W, Turkbey B, Sénégas J, Remmele S, Xu S, Kruecker J, Bernardo M, Wood BJ, Pinto PA, Choyke PL.
Accelerated T2 mapping for characterization of prostate cancer.
Magn Reson Med. 65: 1400-6, 2011.
56)  Krieger A, Iordachita II, Guion P, Singh AK, Kaushal A, Ménard C, Pinto PA, Camphausen K, Fichtinger G, Whitcomb LL.
An MRI-compatible robotic system with hybrid tracking for MRI-guided prostate intervention.
IEEE Trans Biomed Eng. 58: 3049-60, 2011.
57)  Rastinehad AR, Baccala AA, Chung PH, Proano JM, Kruecker J, Xu S, Locklin JK, Turkbey B, Shih J, Bratslavsky G, Linehan WM, Glossop ND, Yan P, Kadoury S, Choyke PL, Wood BJ, Pinto PA.
D"Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging.
J. Urol. 185: 815-20, 2011.
58)  Gannot G, Richardson AM, Rodriguez-Canales J, Pinto PA, Merino MJ, Chuaqui RF, Gillespie JW, Emmert-Buck MR.
Decrease in CD8+ lymphocyte number and altered cytokine profile in human prostate cancer.
Am J Cancer Res. 1: 120-127, 2011.
59)  Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Shah V, Bernardo M, Baccala A, Rastinehad A, Benjamin C, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Documenting the location of systematic transrectal ultrasound-guided prostate biopsies: correlation with multi-parametric MRI.
Cancer Imaging. 11: 31-6, 2011.
60)  Fadahunsi AT, Sanford T, Linehan WM, Pinto PA, Bratslavsky G.
Feasibility and outcomes of partial nephrectomy for resection of at least 20 tumors in a single renal unit.
J. Urol. 185: 49-53, 2011.
61)  Turkbey B, Shah VP, Pang Y, Bernardo M, Xu S, Kruecker J, Locklin J, Baccala AA, Rastinehad AR, Merino MJ, Shih JH, Wood BJ, Pinto PA, Choyke PL.
Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images?.
Radiology. 258: 488-95, 2011.
62)  Pinto PA, Chung PH, Rastinehad AR, Baccala AA, Kruecker J, Benjamin CJ, Xu S, Yan P, Kadoury S, Chua C, Locklin JK, Turkbey B, Shih JH, Gates SP, Buckner C, Bratslavsky G, Linehan WM, Glossop ND, Choyke PL, Wood BJ.
Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging.
J. Urol. 186: 1281-5, 2011.
63)  Turkbey B, Mani H, Shah V, Rastinehad AR, Bernardo M, Pohida T, Pang Y, Daar D, Benjamin C, McKinney YL, Trivedi H, Chua C, Bratslavsky G, Shih JH, Linehan WM, Merino MJ, Choyke PL, Pinto PA.
Multiparametric 3T prostate magnetic resonance imaging to detect cancer: histopathological correlation using prostatectomy specimens processed in customized magnetic resonance imaging based molds.
J. Urol. 186: 1818-24, 2011.
64)  Kearney MF, Lee K, Bagni RK, Wiegand A, Spindler J, Maldarelli F, Pinto PA, Linehan WM, Vocke CD, Delviks-Frankenberry KA, Devere White RW, Del Prete GQ, Mellors JW, Lifson JD, Kewalramani VN, Pathak VK, Coffin JM, Le Grice SF.
Nucleic Acid, Antibody, and Virus Culture Methods to Detect Xenotropic MLV-Related Virus in Human Blood Samples.
Adv Virol. 2011: 272193, 2011.
65)  Sanford TH, Storey BB, Linehan WM, Rogers CA, Pinto PA, Bratslavsky G.
Outcomes and timing for intervention of partial adrenalectomy in patients with a solitary adrenal remnant and history of bilateral phaeochromocytomas.
BJU Int. 107: 571-5, 2011.
66)  Asher KP, Gupta GN, Boris RS, Pinto PA, Linehan WM, Bratslavsky G.
Robot-assisted laparoscopic partial adrenalectomy for pheochromocytoma: the National Cancer Institute technique.
Eur. Urol. 60: 118-24, 2011.
67)  Boris RS, Gupta G, Linehan WM, Pinto PA, Bratslavsky G.
Robot-assisted laparoscopic partial adrenalectomy: initial experience.
Urology. 77: 775-80, 2011.
68)  Boris RS, Benhammou J, Merino M, Pinto PA, Linehan WM, Bratslavsky G.
The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma.
J. Urol. 185: 2050-5, 2011.
69)  Mathur A, Kemp CD, Dutta U, Baid S, Ayala A, Chang RE, Steinberg SM, Papademetriou V, Lange E, Libutti SK, Pingpank JF, Alexander HR, Phan GQ, Hughes M, Linehan WM, Pinto PA, Stratakis CA, Kebebew E.
Consequences of adrenal venous sampling in primary hyperaldosteronism and predictors of unilateral adrenal disease.
J. Am. Coll. Surg. 211: 384-90, 2010.
70)  Hsieh TC, Jarrett TW, Pinto PA.
Current status of nephron-sparing robotic partial nephrectomy.
Curr Opin Urol. 20: 65-9, 2010.
71)  Turkbey B, Xu S, Kruecker J, Locklin J, Pang Y, Bernardo M, Merino MJ, Wood BJ, Choyke PL, Pinto PA.
Documenting the location of prostate biopsies with image fusion.
BJU Int. 107: 53-7, 2010.
72)  Benhammou JN, Boris RS, Pacak K, Pinto PA, Linehan WM, Bratslavsky G.
Functional and oncologic outcomes of partial adrenalectomy for pheochromocytoma in patients with von Hippel-Lindau syndrome after at least 5 years of followup.
J. Urol. 184: 1855-9, 2010.
73)  Erickson HS, Josephson JW, Vira M, Albert PS, Gillespie JW, Rodriguez-Canales J, Pinto PA, Chuaqui RF, Emmert-Buck MR, Coleman JA.
Influence of hypoxia induced by minimally invasive prostatectomy on gene expression: implications for biomarker analysis.
Am J Transl Res. 2: 210-22, 2010.
74)  Pinto PA.
Laparoscopic partial adrenalectomy.
J. Urol. 184: 1860, 2010.
75)  Linehan WM, Bratslavsky G, Pinto PA, Schmidt LS, Neckers L, Bottaro DP, Srinivasan R.
Molecular diagnosis and therapy of kidney cancer.
Annu. Rev. Med. 61: 329-43, 2010.
76)  Gupta GN, Peterson J, Thakore KN, Pinto PA, Linehan WM, Bratslavsky G.
Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm.
J. Urol. 184: 59-63, 2010.
77)  Kaye DR, Storey BB, Pacak K, Pinto PA, Linehan WM, Bratslavsky G.
Partial adrenalectomy: underused first line therapy for small adrenal tumors.
J. Urol. 184: 18-25, 2010.
78)  Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL, Khurana K, Ravizzini GC, Albert PS, Merino MJ, Choyke PL.
Prostate cancer: value of multiparametric MR imaging at 3 T for detection--histopathologic correlation.
Radiology. 255: 89-99, 2010.
79)  Turkbey B, Pinto P, Mani H, Bernando M, Pang Y, McKinney Y, Khurana K, Ravizzini G, Albert P, Merino M, Choyke P.
Prostate Cancer: Value of Multiparametric MR Imaging at 3T for Detection-Histopathologic Correlation.
Radiology. 256: 89-99, 2010.
80)  Chung PH, Srinivasan R, Linehan WM, Pinto PA, Bratslavsky G.
Renal cell carcinoma with metastases to the gallbladder: four cases from the National Cancer Institute (NCI) and review of the literature.
Urol. Oncol. 30: 476-81, 2010.
81)  Liu NW, Khurana K, Sudarshan S, Pinto PA, Linehan WM, Bratslavsky G.
Repeat partial nephrectomy on the solitary kidney: surgical, functional and oncological outcomes.
J. Urol. 183: 1719-24, 2010.
82)  McHone B, Jarrett TW, Pinto PA.
Tips and tricks of laparoscopic partial nephrectomy.
Minerva Urol Nefrol. 62: 273-81, 2010.
83)  Yang Y, Valera VA, Padilla-Nash HM, Sourbier C, Vocke CD, Vira MA, Abu-Asab MS, Bratslavsky G, Tsokos M, Merino MJ, Pinto PA, Srinivasan R, Ried T, Neckers L, Linehan WM.
UOK 262 cell line, fumarate hydratase deficient (FH-/FH-) hereditary leiomyomatosis renal cell carcinoma: in vitro and in vivo model of an aberrant energy metabolic pathway in human cancer.
Cancer Genet. Cytogenet. 196: 45-55, 2010.
84)  Crane NJ, Gillern SM, Tajkarimi K, Levin IW, Pinto PA, Elster EA.
Visual enhancement of laparoscopic partial nephrectomy with 3-charge coupled device camera: assessing intraoperative tissue perfusion and vascular anatomy by visible hemoglobin spectral response.
J. Urol. 184: 1279-85, 2010.
85)  Shah V, Pohida T, Turkbey B, Mani H, Merino M, Pinto PA, Choyke P, Bernardo M.
A method for correlating in vivo prostate magnetic resonance imaging and histopathology using individualized magnetic resonance-based molds.
Rev Sci Instrum. 80: 104301, 2009.
86)  Linehan WM, Pinto PA, Bratslavsky G, Pfaffenroth E, Merino M, Vocke CD, Toro JR, Bottaro D, Neckers L, Schmidt LS, Srinivasan R.
Hereditary kidney cancer: unique opportunity for disease-based therapy.
Cancer. 115: 2252-61, 2009.
87)  Mukherjee S, Richardson AM, Rodriguez-Canales J, Ylaya K, Erickson HS, Player A, Kawasaki ES, Pinto PA, Choyke PL, Merino MJ, Albert PS, Chuaqui RF, Emmert-Buck MR.
Identification of EpCAM as a molecular target of prostate cancer stroma.
Am. J. Pathol. 175: 2277-87, 2009.
88)  Turkbey B, Pinto PA, Choyke PL.
Imaging techniques for prostate cancer: implications for focal therapy.
Nat Rev Urol. 6: 191-203, 2009.
89)  Boris R, Proano M, Linehan WM, Pinto PA, Bratslavsky G.
Initial Experience With Robot Assisted Partial Nephrectomy for Multiple Renal Masses.
J Urol. 182: 1280-6, 2009.
90)  Zaharoff DA, Hoffman BS, Hooper HB, Benjamin CJ, Khurana KK, Hance KW, Rogers CJ, Pinto PA, Schlom J, Greiner JW.
Intravesical immunotherapy of superficial bladder cancer with chitosan/interleukin-12.
Cancer Res. 69: 6192-9, 2009.
91)  Kowalczyk KJ, Hooper HB, Linehan WM, Pinto PA, Wood BJ, Bratslavsky G.
Partial nephrectomy after previous radio frequency ablation: the National Cancer Institute experience.
J. Urol. 182: 2158-63, 2009.
92)  Richstone L, Seideman CA, Reggio E, Bluebond-Langner R, Pinto PA, Trock B, Kavoussi LR.
Pathologic findings in patients with ureteropelvic junction obstruction and crossing vessels.
Urology. 73: 716-9; discussion 719, 2009.
93)  Grubb RL, Deng J, Pinto PA, Mohler JL, Chinnaiyan A, Rubin M, Linehan WM, Liotta LA, Petricoin EF, Wulfkuhle JD.
Pathway biomarker profiling of localized and metastatic human prostate cancer reveal metastatic and prognostic signatures.
J. Proteome Res. 8: 3044-54, 2009.
94)  Erickson HS, Albert PS, Gillespie JW, Rodriguez-Canales J, Marston Linehan W, Pinto PA, Chuaqui RF, Emmert-Buck MR.
Quantitative RT-PCR gene expression analysis of laser microdissected tissue samples.
Nat Protoc. 4: 902-22, 2009.
95)  Rosner I, Bratslavsky G, Pinto PA, Linehan WM.
The clinical implications of the genetics of renal cell carcinoma.
Urol. Oncol. 27: 131-6, 2009.
96)  Novakovick K, Pinto P.
Robotic Surgery. In: Cancer: Principles and Practice of Oncology, 8th Ed.
Philadelphia: Lippincott Williams and Wilkens; 2008. p. 10 [Book Chapter]
97)  Gorbach AM, Wang H, Dhanani NN, Gage FA, Pinto PA, Smith PD, Kirk AD, Elster EA.
Assessment of critical renal ischemia with real-time infrared imaging.
J. Surg. Res. 149: 310-8, 2008.
98)  Stewart L, Glenn GM, Stratton P, Goldstein AM, Merino MJ, Tucker MA, Linehan WM, Toro JR.
Association of germline mutations in the fumarate hydratase gene and uterine fibroids in women with hereditary leiomyomatosis and renal cell cancer.
Arch Dermatol. 144: 1584-92, 2008.
99)  Toro JR, Wei MH, Glenn GM, Weinreich M, Toure O, Vocke C, Turner M, Choyke P, Merino MJ, Pinto PA, Steinberg SM, Schmidt LS, Linehan WM.
BHD mutations, clinical and molecular genetic investigations of Birt-Hogg-Dubé syndrome: a new series of 50 families and a review of published reports.
J. Med. Genet. 45: 321-31, 2008.
100)  Rogers CG, Blatt AM, Miles GE, Linehan WM, Pinto PA.
Concurrent robotic partial adrenalectomy and extra-adrenal pheochromocytoma resection in a pediatric patient with von Hippel-Lindau disease.
J. Endourol. 22: 1501-3, 2008.
101)  Crane NJ, McHone B, Hawksworth J, Pearl JP, Denobile J, Tadaki D, Pinto PA, Levin IW, Elster EA.
Enhanced surgical imaging: laparoscopic vessel identification and assessment of tissue oxygenation.
J. Am. Coll. Surg. 206: 1159-66, 2008.
102)  Liu JJ, Alemozaffar M, McHone B, Dhanani N, Gage F, Pinto PA, Gorbach AM, Elster E.
Evaluation of real-time infrared intraoperative cholangiography in a porcine model.
Surg Endosc. Epub ahead of print, 2008.
103)  Johnson A, Sudarshan S, Liu J, Linehan WM, Pinto PA, Bratslavsky G.
Feasibility and outcomes of repeat partial nephrectomy.
J. Urol. 180: 89-93; discussion 93, 2008.
104)  Hanna BV, Gorbach AM, Gage FA, Pinto PA, Silva JS, Gilfillan LG, Kirk AD, Elster EA.
Intraoperative assessment of critical biliary structures with visible range/infrared image fusion.
J. Am. Coll. Surg. 206: 1227-31, 2008.
105)  Crane NJ, Pinto PA, Hale D, Gage FA, Tadaki D, Kirk AD, Levin IW, Elster EA.
Non-invasive monitoring of tissue oxygenation during laparoscopic donor nephrectomy.
BMC surgery. 8: 8, 2008.
106)  Xu S, Kruecker J, Turkbey B, Glossop N, Singh AK, Choyke P, Pinto P, Wood BJ.
Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies.
Comput. Aided Surg. 13: 255-64, 2008.
107)  Pinto PA.
Renal carcinoma: minimally invasive surgery of the small renal mass.
Urol. Oncol. 27: 335-6, 2008.
108)  Rogers CG, Linehan WM, Pinto PA.
Robotic nephrectomy for kidney cancer in a horseshoe kidney with renal vein tumor thrombus: novel technique for thrombectomy.
J. Endourol. 22: 1561-3; discussion 1563, 2008.
109)  Rogers CG, Singh A, Blatt AM, Linehan WM, Pinto PA.
Robotic partial nephrectomy for complex renal tumors: surgical technique.
Eur. Urol. 53: 514-21, 2008.
110)  Rogers CG, Metwalli A, Blatt AM, Bratslavsky G, Menon M, Linehan WM, Pinto PA.
Robotic partial nephrectomy for renal hilar tumors: a multi-institutional analysis.
J. Urol. 180: 2353-6; discussion 2356, 2008.
111)  Bratslavsky G, Liu JJ, Johnson AD, Sudarshan S, Choyke PL, Linehan WM, Pinto PA.
Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes.
J. Urol. 179: 67-70, 2008.
112)  Mai PL, Korde L, Kramer J, Peters J, Mueller CM, Pfeiffer S, Stratakis CA, Pinto PA, Bratslavsky G, Merino M, Choyke P, Linehan WM, Greene MH.
A possible new syndrome with growth-hormone secreting pituitary adenoma, colonic polyposis, lipomatosis, lentigines and renal carcinoma in association with familial testicular germ cell malignancy: A case report.
J Med Case Reports. 1: 9, 2007.
113)  Begnami MD, Quezado M, Pinto P, Linehan WM, Merino M.
Adenoid cystic/basal cell carcinoma of the prostate: review and update.
Arch. Pathol. Lab. Med. 131: 637-40, 2007.
114)  Ocak I, Bernardo M, Metzger G, Barrett T, Pinto P, Albert PS, Choyke PL.
Dynamic contrast-enhanced MRI of prostate cancer at 3 T: a study of pharmacokinetic parameters.
AJR Am J Roentgenol. 189: 849, 2007.
115)  Zbar B, Glenn G, Merino M, Middelton L, Peterson J, Toro J, Coleman J, Pinto P, Schmidt LS, Choyke P, Linehan WM.
Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development.
J. Urol. 177: 461-5; discussion 465, 2007.
116)  Vira MA, Novakovic KR, Pinto PA, Linehan WM.
Genetic basis of kidney cancer: a model for developing molecular-targeted therapies.
BJU Int. 99: 1223-9, 2007.
117)  Grubb RL, Franks ME, Toro J, Middelton L, Choyke L, Fowler S, Torres-Cabala C, Glenn GM, Choyke P, Merino MJ, Zbar B, Pinto PA, Srinivasan R, Coleman JA, Linehan WM.
Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer.
J. Urol. 177: 2074-80, 2007.
118)  Rodriguez-Canales J, Hanson JC, Tangrea MA, Erickson HS, Albert PS, Wallis BS, Richardson AM, Pinto PA, Linehan WM, Gillespie JW, Merino MJ, Libutti SK, Woodson KG, Emmert-Buck MR, Chuaqui RF.
Identification of a unique epigenetic sub-microenvironment in prostate cancer.
J. Pathol. 211: 410-9, 2007.
119)  Linehan WM, Pinto PA, Srinivasan R, Merino M, Choyke P, Choyke L, Coleman J, Toro J, Glenn G, Vocke C, Zbar B, Schmidt LS, Bottaro D, Neckers L.
Identification of the genes for kidney cancer: opportunity for disease-specific targeted therapeutics.
Clin. Cancer Res. 13: 671s-679s, 2007.
120)  Gannot G, Tangrea MA, Erickson HS, Pinto PA, Hewitt SM, Chuaqui RF, Gillespie JW, Emmert-Buck MR.
Layered peptide array for multiplex immunohistochemistry.
J Mol Diagn. 9: 297-304, 2007.
121)  Sudarshan S, Pinto PA, Neckers L, Linehan WM.
Mechanisms of disease: hereditary leiomyomatosis and renal cell cancer--a distinct form of hereditary kidney cancer.
Nat Clin Pract Urol. 4: 104-10, 2007.
122)  Palau M, Torres-Cabala C, Linehan W, Merino M.
Primary synovial sarcoma of the kidney with rhabdoid features.
International Journal of Surgical Pathology. 15: 421-428, 2007.
123)  Stone MJ, Venkatesan AM, Locklin J, Pinto P, Linehan M, Wood BJ.
Radiofrequency ablation of renal tumors.
Tech Vasc Interv Radiol. 10: 132-9, 2007.
124)  Coleman J, Singh A, Pinto P, Phillips J, Pritchard W, Wray-Cahen D, Wood BJ.
Radiofrequency-assisted laparoscopic partial nephrectomy: clinical and histologic results.
J. Endourol. 21: 600-5, 2007.
125)  Merino MJ, Torres-Cabala C, Pinto P, Linehan WM.
The morphologic spectrum of kidney tumors in hereditary leiomyomatosis and renal cell carcinoma (HLRCC) syndrome.
Am. J. Surg. Pathol. 31: 1578-85, 2007.
126)  Kaji P, Carrasquillo JA, Linehan WM, Chen CC, Eisenhofer G, Pinto PA, Lai EW, Pacak K.
The role of 6-[18F]fluorodopamine positron emission tomography in the localization of adrenal pheochromocytoma associated with von Hippel-Lindau syndrome.
Eur. J. Endocrinol. 156: 483-7, 2007.
127)  Timmers HJ, Carrasquillo JA, Whatley M, Eisenhofer G, Chen CC, Ling A, Linehan WM, Pinto PA, Adams KT, Pacak K.
Usefulness of standardized uptake values for distinguishing adrenal glands with pheochromocytoma from normal adrenal glands by use of 6-18F-fluorodopamine PET.
J. Nucl. Med. 48: 1940-4, 2007.
128)  Lattouf J, Arlen PM, Pinto PA, Gulley JL.
A phase I feasibility study of an intraprostatic prostate-specific antigen-based vaccine in patients with prostate cancer with local failure after radiation therapy or clinical progression on androgen-deprivation therapy in the absence of local definitive therapy.
Clin Genitourin Cancer. 5: 89-92, 2006.
129)  Singh AK, Ménard C, Guion P, Simone NL, Smith S, Crouse NS, Godette DJ, Cooley-Zgela T, Sciuto LC, Coleman J, Pinto P, Albert PS, Camphausen K, Coleman CN.
Intrarectal amifostine suspension may protect against acute proctitis during radiation therapy for prostate cancer: a pilot study.
Int. J. Radiat. Oncol. Biol. Phys. 65: 1008-13, 2006.
130)  Lattouf J, Srinivasan R, Pinto PA, Linehan WM, Neckers L.
Mechanisms of disease: the role of heat-shock protein 90 in genitourinary malignancy.
Nat Clin Pract Urol. 3: 590-601, 2006.
131)  Challacombe B, Patriciu A, Glass J, Aron M, Jarrett T, Kim F, Pinto P, Stoianovici D, Smeeton N, Tiptaft R, Kavoussi L, Dasgupta P.
A randomized controlled trial of human versus robotic and telerobotic access to the kidney as the first step in percutaneous nephrolithotomy.
Comput. Aided Surg. 10: 165-71, 2005.
132)  Rha KH, Varkarakis IM, Ong AM, Pinto PA, Molmenti EP, Jarrett TW.
Endourologic management of duodenal calculi in pancreas-kidney transplantation.
Urol. Int. 74: 371-2, 2005.
133)  Kirk AD, Pinto PA.
Laparoscopic kidney donation: looking more than skin deep.
Am. J. Transplant. 5: 1177-8, 2005.
134)  Grubb RL, Choyke PL, Pinto PA, Linehan WM, Walther MM.
Management of von Hippel-Lindau-associated kidney cancer.
Nat Clin Pract Urol. 2: 248-55, 2005.
135)  Diner EK, Williams CR, Behari A, Pinto PA, Linehan WM, Walther MM.
Metastatic renal cell carcinoma to contralateral ureter presenting as acute obstructive renal failure after radical nephrectomy.
Urology. 65: 1001, 2005.
Click Here to View Collapsed Bibliography.

This page was last updated on 8/20/2014.